4.8 Letter

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 386, 期 10, 页码 995-998

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2119407

关键词

-

资金

  1. Center for Research on Influenza Pathogenesis - National Institutes of Allergy and Infectious Diseases [HHSN272201400008C]
  2. Center for Research on Influenza Pathogenesis and Transmission - National Institutes of Allergy and Infectious Diseases [75N93021C00014]
  3. Japan Agency for Medical Research and Development [JP20fk0108412, JP21fk0108615, JP21fk0108104, JP20nk0101632, JP21wm0125002]
  4. Ministry of Health, Labor, and Welfare, Japan [20HA2007]
  5. U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense
  6. Defense Health Agency [W911QY2090012]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据